Phosphorylated HER3 and FITC-labeled trastuzumab immunohistochemistry in patients with HER2-positive breast cancer treated with adjuvant trastuzumab
Keyword(s):
Keyword(s):
2021 ◽
2013 ◽
2013 ◽
Keyword(s):
2020 ◽
2015 ◽